chrX-79171491-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032553.3(GPR174):c.484T>A(p.Ser162Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,207,969 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S162P) has been classified as Benign.
Frequency
Consequence
NM_032553.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR174 | NM_032553.3 | c.484T>A | p.Ser162Thr | missense_variant | 3/3 | ENST00000645147.2 | |
GPR174 | XM_047442579.1 | c.484T>A | p.Ser162Thr | missense_variant | 3/3 | ||
GPR174 | XM_047442580.1 | c.484T>A | p.Ser162Thr | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR174 | ENST00000645147.2 | c.484T>A | p.Ser162Thr | missense_variant | 3/3 | NM_032553.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000273 AC: 3AN: 109991Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32239
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182645Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67305
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097978Hom.: 0 Cov.: 47 AF XY: 0.00 AC XY: 0AN XY: 363366
GnomAD4 genome AF: 0.0000273 AC: 3AN: 109991Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32239
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at